Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Patients with sporadic and familial amyotrophic lateral sclerosis found value in genetic testing.

Molecular genetics & genomic medicine - 1 Mar 2018

Wagner Karin N, Nagaraja Haikady N, Allain Dawn C, Quick Adam, Kolb Stephen J, Roggenbuck Jennifer

Abstract excerpt

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is increasingly recognized as a genetic disease. There is no consensus, however, as to the role of genetic testing in the care of the ALS patient. METHODS: We conducted a survey to study patient access, attitudes, and experience with ALS genetic testing among patients enrolled in a US ALS registry. RESULTS: Among 449 survey respondents, 156 (34.7%) were offered...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis
Share to Amyotrophic Lateral Sclerosis Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Attitude to Health

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Health Knowledge, Attitudes, Practice

Share to Neurogenetic and Muscular Disorders Research

Share to Surveys and Questionnaires

Source

Open in PubMed Open full text

Identifiers

PMID: 29266834
DOI: 10.1002/mgg3.360
PMCID: PMC5902388

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Patients with sporadic and familial amyotrophic lateral sclerosis found value in genetic testing.PMID 29266834Read ↗

Genetic testing in ALS: A survey of current practices.Semantic proximity Read ↗

Presymptomatic ALS genetic counseling and testingSemantic proximity Read ↗

Evidence‐based consensus guidelines for ALS genetic testing and counselingSemantic proximity Read ↗

Incorporating Genetic Testing Into the Care of Patients With Amyotrophic Lateral Sclerosis/Frontotemporal Degeneration Spectrum DisordersSemantic proximity Read ↗

The use of genetic testing in amyotrophic lateral sclerosis (ALS): a practical approach.Semantic proximity Read ↗

The Impact of Sponsored Genetic Testing in 170 Consecutive Consenting Patients With Amyotrophic Lateral Sclerosis: A Single-Site Retrospective Review.Semantic proximity Read ↗

Update and recommendations on genetic testing for amyotrophic lateral sclerosis in clinical practice: a Brazilian expert view.Semantic proximity Read ↗

How the prospect of a clinical trial impacts decision-making for predictive genetic testing in amyotrophic lateral sclerosisSemantic proximity Read ↗

How the prospect of a clinical trial impacts decision-making for predictive genetic testing in ALS.Semantic proximity Read ↗

Lack of consensus in ALS genetic testing practices and divergent views between ALS clinicians and patients.Semantic proximity Read ↗

Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for cliniciansSemantic proximity Read ↗

The impact of age on genetic testing decisions in amyotrophic lateral sclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.